{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:36:56Z","timestamp":1790948216938,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T00:00:00Z","timestamp":1693180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T00:00:00Z","timestamp":1693180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["204820\/Z\/16\/Z"],"award-info":[{"award-number":["204820\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RG\/13\/7\/30099"],"award-info":[{"award-number":["RG\/13\/7\/30099"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>COVID-19, caused by SARS-CoV-2, is a respiratory disease associated with inflammation and endotheliitis. Mechanisms underling inflammatory processes are unclear, but angiotensin converting enzyme 2 (ACE2), the receptor which binds the spike protein of SARS-CoV-2 may be important. Here we investigated whether spike protein binding to ACE2 induces inflammation in endothelial cells and determined the role of ACE2 in this process. Human endothelial cells were exposed to SARS-CoV-2 spike protein, S1 subunit (rS1p) and pro-inflammatory signaling and inflammatory mediators assessed. ACE2 was modulated pharmacologically and by siRNA. Endothelial cells were also exposed to SARS-CoV-2. rSP1 increased production of IL-6, MCP-1, ICAM-1 and PAI-1, and induced NFkB activation via ACE2 in endothelial cells. rS1p increased microparticle formation, a functional marker of endothelial injury. ACE2 interacting proteins involved in inflammation and RNA biology were identified in rS1p-treated cells. Neither ACE2 expression nor ACE2 enzymatic function were affected by rSP1. Endothelial cells exposed to SARS-CoV-2 virus did not exhibit viral replication. We demonstrate that rSP1 induces endothelial inflammation via ACE2 through processes that are independent of ACE2 enzymatic activity and viral replication. We define a novel role for ACE2 in COVID-19- associated endotheliitis.<\/jats:p>","DOI":"10.1038\/s41598-023-41115-3","type":"journal-article","created":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T16:05:13Z","timestamp":1693238713000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["SARS-CoV-2 spike protein induces endothelial inflammation via ACE2 independently of viral replication"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8658-7994","authenticated-orcid":false,"given":"Augusto C.","family":"Montezano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia L.","family":"Camargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheon","family":"Mary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla B","family":"Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J","family":"Rios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rheure A.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Beattie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Herder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka M.","family":"Szemiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"McFarlane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Palmarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0670-0887","authenticated-orcid":false,"given":"Rhian M.","family":"Touyz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,28]]},"reference":[{"key":"41115_CR1","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/cvr\/cvaa106","volume":"116","author":"TJ Guzik","year":"2020","unstructured":"Guzik, T. J. et al. COVID-19 and the cardiovascular system: Implications for risk assessment, diagnosis, and treatment options. Cardiovasc. Res. 116, 1666\u20131687 (2020).","journal-title":"Cardiovasc. Res."},{"key":"41115_CR2","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41569-020-0413-9","volume":"17","author":"M Nishiga","year":"2020","unstructured":"Nishiga, M., Wang, D. W., Han, Y., Lewis, D. B. & Wu, J. C. COVID-19 and cardiovascular disease: From basic mechanisms to clinical perspectives. Nat. Rev. Cardiol. 17, 543\u2013558 (2020).","journal-title":"Nat. Rev. Cardiol."},{"key":"41115_CR3","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/CIRCULATIONAHA.120.047549","volume":"142","author":"PP Liu","year":"2020","unstructured":"Liu, P. P., Blet, A., Smyth, D. & Li, H. The science underlying COVID-19: Implications for the cardiovascular system. Circulation 142, 68\u201378 (2020).","journal-title":"Circulation"},{"key":"41115_CR4","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00127-20","author":"Y Wan","year":"2020","unstructured":"Wan, Y., Shang, J., Graham, R., Baric, R. S. & Li, F. Receptor recognition by the novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS coronavirus. J. Virol. https:\/\/doi.org\/10.1128\/JVI.00127-20 (2020).","journal-title":"J. Virol."},{"key":"41115_CR5","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270\u2013273 (2020).","journal-title":"Nature"},{"key":"41115_CR6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271-280.e278 (2020).","journal-title":"Cell"},{"key":"41115_CR7","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11906-014-0431-2","volume":"16","author":"AC Montezano","year":"2014","unstructured":"Montezano, A. C., Nguyen Dinh Cat, A., Rios, F. J. & Touyz, R. M. Angiotensin II and vascular injury. Curr. Hypertens. Rep. 16, 431 (2014).","journal-title":"Curr. Hypertens. Rep."},{"key":"41115_CR8","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1042\/CS20200480","volume":"135","author":"J Kuriakose","year":"2021","unstructured":"Kuriakose, J., Montezano, A. C. & Touyz, R. M. ACE2\/Ang-(1\u20137)\/Mas1 axis and the vascular system: Vasoprotection to COVID-19-associated vascular disease. Clin. Sci. 135, 387\u2013407 (2021).","journal-title":"Clin. Sci."},{"key":"41115_CR9","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.3390\/jcm9051417","volume":"9","author":"C Sardu","year":"2020","unstructured":"Sardu, C. et al. Hypertension, thrombosis, kidney failure, and diabetes: Is COVID-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence. J. Clin. Med. 9, 1417 (2020).","journal-title":"J. Clin. Med."},{"key":"41115_CR10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41577-020-0343-0","volume":"20","author":"LA Teuwen","year":"2020","unstructured":"Teuwen, L. A., Geldhof, V., Pasut, A. & Carmeliet, P. COVID-19: The vasculature unleashed. Nat. Rev. Immunol. 20, 389\u2013391 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"41115_CR11","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","volume":"395","author":"Z Varga","year":"2020","unstructured":"Varga, Z. et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet 395, 1417\u20131418 (2020).","journal-title":"Lancet"},{"key":"41115_CR12","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1053\/j.gastro.2008.10.055","volume":"136","author":"SM Camargo","year":"2009","unstructured":"Camargo, S. M. et al. Tissue-specific amino acid transporter partners ACE2 and collectrin differentially interact with hartnup mutations. Gastroenterology 136, 872\u2013882 (2009).","journal-title":"Gastroenterology"},{"key":"41115_CR13","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/s41590-020-0778-2","volume":"21","author":"ES Winkler","year":"2020","unstructured":"Winkler, E. S. et al. SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function. Nat. Immunol. 21, 1327\u20131335 (2020).","journal-title":"Nat. Immunol."},{"key":"41115_CR14","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00408-020-00408-4","volume":"198","author":"F Scialo","year":"2020","unstructured":"Scialo, F. et al. ACE2: The major cell entry receptor for SARS-CoV-2. Lung 198, 867\u2013877 (2020).","journal-title":"Lung"},{"key":"41115_CR15","doi-asserted-by":"crossref","first-page":"H958","DOI":"10.1152\/ajpheart.00723.2018","volume":"316","author":"RAS Santos","year":"2019","unstructured":"Santos, R. A. S. et al. The renin-angiotensin system: Going beyond the classical paradigms. Am. J. Physiol. Heart Circ. Physiol. 316, H958\u2013H970 (2019).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"41115_CR16","first-page":"103820","volume":"78","author":"FJ Gonz\u00e1lez-Ruiz","year":"2022","unstructured":"Gonz\u00e1lez-Ruiz, F. J. et al. Endotheliitis, shunts, and ventilation-perfusion mismatch in coronavirus disease 2019: A literature review of disease mechanisms. Ann. Med. Surg. 78, 103820 (2022).","journal-title":"Ann. Med. Surg."},{"key":"41115_CR17","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00281-022-00928-6","volume":"44","author":"S Giryes","year":"2022","unstructured":"Giryes, S., Bragazzi, N. L., Bridgewood, C., De Marco, G. & McGonagle, D. COVID-19 vasculitis and vasculopathy-distinct immunopathology emerging from the close juxtaposition of Type II pneumocytes and pulmonary endothelial cells. Semin. Immunopathol. 44, 375\u2013390 (2022).","journal-title":"Semin. Immunopathol."},{"key":"41115_CR18","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12967-022-03346-2","volume":"20","author":"M Haffke","year":"2022","unstructured":"Haffke, M. et al. Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME\/CFS). J. Transl. Med. 20, 138 (2022).","journal-title":"J. Transl. Med."},{"key":"41115_CR19","doi-asserted-by":"crossref","first-page":"ytac061","DOI":"10.1093\/ehjcr\/ytac061","volume":"6","author":"V Valiton","year":"2022","unstructured":"Valiton, V., Bendjelid, K., Pache, J. C., Roffi, M. & Meyer, P. Coronavirus disease 2019-associated coronary endotheliitis and thrombotic microangiopathy causing cardiogenic shock: A case report. Eur. Heart J. Case Rep. 6, ytac061 (2022).","journal-title":"Eur. Heart J. Case Rep."},{"key":"41115_CR20","doi-asserted-by":"crossref","first-page":"106975","DOI":"10.1016\/j.vph.2022.106975","volume":"144","author":"E Oikonomou","year":"2022","unstructured":"Oikonomou, E. et al. Endothelial dysfunction in acute and long standing COVID-19: A prospective cohort study. Vascul. Pharmacol. 144, 106975 (2022).","journal-title":"Vascul. Pharmacol."},{"key":"41115_CR21","doi-asserted-by":"crossref","first-page":"e52744","DOI":"10.15252\/embr.202152744","volume":"22","author":"VV Thacker","year":"2021","unstructured":"Thacker, V. V. et al. Rapid endotheliitis and vascular damage characterize SARS-CoV-2 infection in a human lung-on-chip model. EMBO Rep. 22, e52744 (2021).","journal-title":"EMBO Rep."},{"key":"41115_CR22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1042\/CS20120309","volume":"124","author":"D Burger","year":"2013","unstructured":"Burger, D. et al. Microparticles: Biomarkers and beyond. Clin. Sci. 124, 423\u2013441 (2013).","journal-title":"Clin. Sci."},{"key":"41115_CR23","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497\u2013506 (2020).","journal-title":"Lancet"},{"key":"41115_CR24","doi-asserted-by":"crossref","first-page":"173620","DOI":"10.1016\/j.ejphar.2020.173620","volume":"890","author":"A Yarmohammadi","year":"2021","unstructured":"Yarmohammadi, A., Yarmohammadi, M., Fakhri, S. & Khan, H. Targeting pivotal inflammatory pathways in COVID-19: A mechanistic review. Eur. J. Pharmacol. 890, 173620 (2021).","journal-title":"Eur. J. Pharmacol."},{"key":"41115_CR25","doi-asserted-by":"crossref","first-page":"7334","DOI":"10.1038\/s41598-021-86676-3","volume":"11","author":"Y Gu","year":"2021","unstructured":"Gu, Y. et al. PaO. Sci. Rep. 11, 7334 (2021).","journal-title":"Sci. Rep."},{"key":"41115_CR26","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","volume":"26","author":"DM Del Valle","year":"2020","unstructured":"Del Valle, D. M. et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat. Med. 26, 1636\u20131643 (2020).","journal-title":"Nat. Med."},{"key":"41115_CR27","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/ajh.25982","volume":"95","author":"TC Hanff","year":"2020","unstructured":"Hanff, T. C., Mohareb, A. M., Giri, J., Cohen, J. B. & Chirinos, J. A. Thrombosis in COVID-19. Am. J. Hematol. 95, 1578\u20131589 (2020).","journal-title":"Am. J. Hematol."},{"key":"41115_CR28","doi-asserted-by":"crossref","first-page":"24287","DOI":"10.1074\/jbc.270.41.24287","volume":"270","author":"Z Zhang","year":"1995","unstructured":"Zhang, Z., Fuentes, N. L. & Fuller, G. M. Characterization of the IL-6 responsive elements in the gamma fibrinogen gene promoter. J. Biol. Chem. 270, 24287\u201324291 (1995).","journal-title":"J. Biol. Chem."},{"key":"41115_CR29","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1038\/s41418-020-00633-7","volume":"27","author":"T Matsuyama","year":"2020","unstructured":"Matsuyama, T., Kubli, S. P., Yoshinaga, S. K., Pfeffer, K. & Mak, T. W. An aberrant STAT pathway is central to COVID-19. Cell Death Differ. 27, 3209\u20133225 (2020).","journal-title":"Cell Death Differ."},{"key":"41115_CR30","doi-asserted-by":"crossref","first-page":"402","DOI":"10.7150\/ijms.67815","volume":"19","author":"S Feng","year":"2022","unstructured":"Feng, S. et al. Potential genes associated with COVID-19 and comorbidity. Int. J. Med. Sci. 19, 402\u2013415 (2022).","journal-title":"Int. J. Med. Sci."},{"key":"41115_CR31","doi-asserted-by":"crossref","first-page":"847809","DOI":"10.3389\/fcvm.2022.847809","volume":"9","author":"RL Camargo","year":"2022","unstructured":"Camargo, R. L. et al. Plasma angiotensin II is increased in critical coronavirus disease 2019. Front. Cardiovasc. Med. 9, 847809 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"41115_CR32","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1161\/HYPERTENSIONAHA.120.15829","volume":"76","author":"JA Chirinos","year":"2020","unstructured":"Chirinos, J. A. et al. Clinical and proteomic correlates of plasma ACE2 (angiotensin-converting enzyme 2) in human heart failure. Hypertension 76, 1526\u20131536 (2020).","journal-title":"Hypertension"},{"key":"41115_CR33","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/path.2357","volume":"215","author":"JC Sluimer","year":"2008","unstructured":"Sluimer, J. C. et al. Angiotensin-converting enzyme 2 (ACE2) expression and activity in human carotid atherosclerotic lesions. J. Pathol. 215, 273\u2013279 (2008).","journal-title":"J. Pathol."},{"key":"41115_CR34","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/eurheartj\/ehi114","volume":"26","author":"LM Burrell","year":"2005","unstructured":"Burrell, L. M. et al. Myocardial infarction increases ACE2 expression in rat and humans. Eur. Heart J. 26, 369\u2013375 (2005) (discussion 322\u2013364).","journal-title":"Eur. Heart J."},{"key":"41115_CR35","doi-asserted-by":"crossref","first-page":"e0198144","DOI":"10.1371\/journal.pone.0198144","volume":"13","author":"J Ramchand","year":"2018","unstructured":"Ramchand, J., Patel, S. K., Srivastava, P. M., Farouque, O. & Burrell, L. M. Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease. PLoS ONE 13, e0198144 (2018).","journal-title":"PLoS ONE"},{"key":"41115_CR36","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1021\/acs.jpcb.0c11321","volume":"125","author":"BJ Williams-Noonan","year":"2021","unstructured":"Williams-Noonan, B. J., Todorova, N., Kulkarni, K., Aguilar, M. I. & Yarovsky, I. An active site inhibitor induces conformational penalties for ACE2 recognition by the spike protein of SARS-CoV-2. J. Phys. Chem. B 125, 2533\u20132550 (2021).","journal-title":"J. Phys. Chem. B"},{"key":"41115_CR37","doi-asserted-by":"crossref","first-page":"101695","DOI":"10.1016\/j.jbc.2022.101695","volume":"298","author":"JP Robles","year":"2022","unstructured":"Robles, J. P. et al. The spike protein of SARS-CoV-2 induces endothelial inflammation through integrin \u03b15\u03b21 and NF-\u03baB signaling. J. Biol. Chem. 298, 101695 (2022).","journal-title":"J. Biol. Chem."},{"key":"41115_CR38","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.68563","author":"S Khan","year":"2021","unstructured":"Khan, S. et al. SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-\u03baB pathway. Elife https:\/\/doi.org\/10.7554\/eLife.68563 (2021).","journal-title":"Elife"},{"key":"41115_CR39","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3390\/ph13060132","volume":"13","author":"A Palmeira","year":"2020","unstructured":"Palmeira, A. et al. Preliminary virtual screening studies to identify GRP78 inhibitors which may interfere with SARS-CoV-2 infection. Pharmaceuticals 13, 132 (2020).","journal-title":"Pharmaceuticals"},{"key":"41115_CR40","doi-asserted-by":"crossref","unstructured":"Aguiar, J. A. et al. Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue. Eur. Respir. J. 56, 1\u201317 (2020).","DOI":"10.1183\/13993003.01123-2020"},{"key":"41115_CR41","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) Method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"key":"41115_CR42","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12885-019-5489-4","volume":"19","author":"CM Blair","year":"2019","unstructured":"Blair, C. M., Walsh, N. M., Littman, B. H., Marcoux, F. W. & Baillie, G. S. Targeting B-Raf inhibitor resistant melanoma with novel cell penetrating peptide disrupters of PDE8A-C-Raf. BMC Cancer 19, 266 (2019).","journal-title":"BMC Cancer"},{"key":"41115_CR43","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.009388","author":"AC Montezano","year":"2018","unstructured":"Montezano, A. C. et al. NADPH oxidase 5 is a pro-contractile nox isoform and a point of cross-talk for calcium and redox signaling-implications in vascular function. J. Am. Heart Assoc. https:\/\/doi.org\/10.1161\/JAHA.118.009388 (2018).","journal-title":"J. Am. Heart Assoc."},{"key":"41115_CR44","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nbt.1511","volume":"26","author":"J Cox","year":"2008","unstructured":"Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367\u20131372 (2008).","journal-title":"Nat. Biotechnol."},{"key":"41115_CR45","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nmeth.3901","volume":"13","author":"S Tyanova","year":"2016","unstructured":"Tyanova, S. et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods 13, 731\u2013740 (2016).","journal-title":"Nat. Methods"},{"key":"41115_CR46","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1021\/acs.jproteome.8b00702","volume":"18","author":"NT Doncheva","year":"2019","unstructured":"Doncheva, N. T., Morris, J. H., Gorodkin, J. & Jensen, L. J. Cytoscape StringApp: Network analysis and visualization of proteomics data. J. Proteome Res. 18, 623\u2013632 (2019).","journal-title":"J. Proteome Res."},{"key":"41115_CR47","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","volume":"25","author":"G Bindea","year":"2009","unstructured":"Bindea, G. et al. ClueGO: A cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics 25, 1091\u20131093 (2009).","journal-title":"Bioinformatics"},{"key":"41115_CR48","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2009","unstructured":"Huang, D. W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44\u201357 (2009).","journal-title":"Nat. Protoc."},{"key":"41115_CR49","doi-asserted-by":"crossref","first-page":"e3001091","DOI":"10.1371\/journal.pbio.3001091","volume":"19","author":"SJ Rihn","year":"2021","unstructured":"Rihn, S. J. et al. A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research. PLoS Biol. 19, e3001091 (2021).","journal-title":"PLoS Biol."},{"key":"41115_CR50","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/infdis\/jiab147","volume":"224","author":"K Dee","year":"2021","unstructured":"Dee, K. et al. Human rhinovirus infection blocks severe acute respiratory syndrome coronavirus 2 replication within the respiratory epithelium: Implications for COVID-19 epidemiology. J. Infect. Dis. 224, 31\u201338 (2021).","journal-title":"J. Infect. Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-41115-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-41115-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-41115-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T15:28:27Z","timestamp":1700580507000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-41115-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,28]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["41115"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-41115-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,28]]},"assertion":[{"value":"6 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14086"}}